ChromoGenics AB (CHRO.ST)

SEK 9.8

(0.2%)

Net Debt Summary of ChromoGenics AB

ChromoGenics AB's latest annual net debt in 2023 was 58.89 Million SEK , up 47.39% from previous year.
ChromoGenics AB's latest quarterly net debt in 2024 Q1 was 65.09 Million SEK , up 10.53% from previous quarter.
ChromoGenics AB reported annual net debt of 39.95 Million SEK in 2022, down -6.74% from previous year.
ChromoGenics AB reported annual net debt of 42.84 Million SEK in 2021, up 217.78% from previous year.
ChromoGenics AB reported quarterly net debt of 20.21 Million SEK for 2024 Q2, down -68.95% from previous quarter.
ChromoGenics AB reported quarterly net debt of 61.47 Million SEK for 2023 Q2, up 27.34% from previous quarter.

Annual Net Debt Chart of ChromoGenics AB (2023 - 2013)

Historical Annual Net Debt of ChromoGenics AB (2023 - 2013)

Year	Net Debt	Net Debt Growth
2023	58.89 Million SEK	47.39%
2022	39.95 Million SEK	-6.74%
2021	42.84 Million SEK	217.78%
2020	-36.38 Million SEK	-258.8%
2019	22.91 Million SEK	-45.2%
2018	41.8 Million SEK	284.78%
2017	10.86 Million SEK	-73.6%
2016	41.15 Million SEK	6.19%
2015	38.75 Million SEK	431.33%
2014	7.29 Million SEK	133.74%
2013	-21.61 Million SEK	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	65.09 Million SEK	10.53%
2024 Q2	20.21 Million SEK	-68.95%
2023 Q2	61.47 Million SEK	27.34%
2023 Q3	47.37 Million SEK	-22.95%
2023 FY	58.89 Million SEK	47.39%
2023 Q1	48.27 Million SEK	20.82%
2023 Q4	58.89 Million SEK	24.33%
2022 Q3	54.9 Million SEK	30.96%
2022 Q4	39.95 Million SEK	-27.22%
2022 FY	39.95 Million SEK	-6.74%
2022 Q1	13.82 Million SEK	-67.73%
2022 Q2	41.92 Million SEK	203.25%
2021 Q2	10.51 Million SEK	194.85%
2021 Q1	-11.08 Million SEK	69.52%
2021 Q3	31.72 Million SEK	201.65%
2021 FY	42.84 Million SEK	217.78%
2021 Q4	42.84 Million SEK	35.06%
2020 Q2	13.48 Million SEK	215.99%
2020 Q1	-11.62 Million SEK	-150.74%
2020 FY	-36.38 Million SEK	-258.8%
2020 Q4	-36.38 Million SEK	-199.46%
2020 Q3	36.57 Million SEK	171.3%
2019 Q3	1.44 Million SEK	-95.84%
2019 Q4	22.91 Million SEK	1483.28%
2019 FY	22.91 Million SEK	-45.2%
2019 Q1	6.64 Million SEK	-84.1%
2019 Q2	34.82 Million SEK	423.92%
2018 Q2	20.24 Million SEK	1345.18%
2018 Q4	41.8 Million SEK	12.42%
2018 FY	41.8 Million SEK	284.78%
2018 Q1	1.4 Million SEK	-87.11%
2018 Q3	37.18 Million SEK	83.66%
2017 Q2	-17.29 Million SEK	47.35%
2017 Q1	-32.84 Million SEK	-179.81%
2017 FY	10.86 Million SEK	-73.6%
2017 Q4	10.86 Million SEK	254.53%
2017 Q3	-7.03 Million SEK	59.34%
2016 Q3	52.55 Million SEK	0.0%
2016 FY	41.15 Million SEK	6.19%
2016 Q4	41.15 Million SEK	-21.7%
2016 Q1	10.91 Million SEK	-71.84%
2015 Q4	38.75 Million SEK	0.0%
2015 FY	38.75 Million SEK	431.33%
2014 FY	7.29 Million SEK	133.74%
2013 FY	-21.61 Million SEK	0.0%

Peer Net Debt Comparison of ChromoGenics AB

Name	Net Debt	Net Debt Difference
Balco Group AB	241.61 Million SEK	75.625%
Byggmax Group AB (publ)	2.73 Billion SEK	97.844%
Ecoclime Group AB (publ)	-29.52 Million SEK	299.465%
FM Mattsson Mora Group AB (publ)	-32.81 Million SEK	279.462%
Inwido AB (publ)	1.28 Billion SEK	95.4%
Lindab International AB (publ)	3.03 Billion SEK	98.061%
NIBE Industrier AB (publ)	18.71 Billion SEK	99.685%
Nordic Waterproofing Holding AB (publ)	724.3 Million SEK	91.869%
Polyplank AB (publ)	7.86 Million SEK	-649.097%
Svedbergs i Dalstorp AB (publ)	930.8 Million SEK	93.673%
Systemair AB (publ)	1.04 Billion SEK	94.38%